Amneal Reaffirms 2024 Revenue Guidance Of $2.55B-$2.65B Versus Consensus Of $2.60B, With Adjusted EBITDA of $0.53-$0.63 Compared To Guidance Of $0.58
Amneal Reaffirms 2024 Revenue Guidance Of $2.55B-$2.65B Versus Consensus Of $2.60B, With Adjusted EBITDA of $0.53-$0.63 Compared To Guidance Of $0.58
Amneal重申2024年的收入指导为25.5亿美元至26.5亿美元，而预期为26.0亿美元，调整后的息税折旧摊销前利润为0.53美元至0.63美元，而预期为0.58美元
Amneal Reaffirms 2024 Revenue Guidance Of $2.55B-$2.65B Versus Consensus Of $2.60B, With Adjusted EBITDA of $0.53-$0.63 Compared To Guidance Of $0.58
Amneal重申2024年的收入指导为25.5亿美元至26.5亿美元，而预期为26.0亿美元，调整后的息税折旧摊销前利润为0.53美元至0.63美元，而预期为0.58美元
译文内容由第三方软件翻译。
以上内容仅用作资讯或教育之目的，不构成与富途相关的任何投资建议。富途竭力但不能保证上述全部内容的真实性、准确性和原创性。